Overview Pembrolizumab (Keytruda): CADTH Reimbursement Advice: Indicator: Together with chemotherapy, for that treatment method of Grownup clients with locally recurrent unresectable or metastatic triple-negative breast cancer who've not obtained prior chemotherapy for metastatic ailment and whose tumours Specific programmed cell Demise-ligand 1 (combined beneficial rating ≥ 10) as de... https://derricki890bbz2.59bloggers.com/profile